This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Sponsorship

16th Annual Market Access Summit

November 13-14, 2017

Arcadian Court, Toronto

CRA’s Life Sciences Practice is a sponsor of this conference.
For more information on this event, click here.

Related capabilities

Share

Pricing & Market Access
Infographics

Rare disease PMA trends in France: Price achieved vs. disease prevalence

In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.
Pricing & Market Access
Infographics

Rare disease PMA trends in France: Price achieved vs. type of clinical comparator arm

As part of the CRA Life Sciences series on leveraging RADAR, our orphan drug data repository, we analyzed the relationship between annual list prices achieved

Explore our thinking

Life Sciences
CRA Hosted Event

January 13, 2026

San Francisco, CA

What Happens if U.S. Pharmaceutical Prices Become the World’s Benchmark?

The U.S. Most Favored Nation (MFN) Executive Order could upend global drug pricing as we know it. Some manufacturers are now vowing to launch only at U.S....